ProPhase Labs, Inc.
PRPH
$0.02
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -43.52% | -41.97% | -35.82% | 908.80% | -11.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.52% | -41.97% | -35.82% | 908.80% | -11.64% |
| Cost of Revenue | -38.10% | -56.24% | -57.21% | 30.64% | -46.38% |
| Gross Profit | -60.98% | 135.09% | 1,022.67% | 126.40% | 181.44% |
| SG&A Expenses | -49.79% | -48.08% | -48.99% | 9.59% | 9.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.81% | -49.68% | -50.68% | 9.45% | -4.41% |
| Operating Income | 49.76% | 50.99% | 53.28% | 8.32% | 3.00% |
| Income Before Tax | 36.79% | 41.70% | 44.75% | 0.56% | -2.87% |
| Income Tax Expenses | -95.27% | -85.92% | -100.00% | 247.72% | 236.30% |
| Earnings from Continuing Operations | 52.52% | 50.57% | 52.78% | -103.95% | -94.83% |
| Earnings from Discontinued Operations | -100.00% | -100.00% | 325.16% | 357.39% | 535.78% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.38% | 44.21% | 72.37% | -50.25% | -57.55% |
| EBIT | 49.76% | 50.99% | 53.28% | 8.32% | 3.00% |
| EBITDA | 53.58% | 55.67% | 59.27% | 6.92% | 1.14% |
| EPS Basic | 85.15% | 82.46% | 92.12% | -4.83% | -20.36% |
| Normalized Basic EPS | 80.03% | 81.90% | 80.37% | 40.09% | 28.72% |
| EPS Diluted | 85.17% | 82.48% | 92.11% | -5.02% | -20.49% |
| Normalized Diluted EPS | 80.03% | 81.90% | 80.37% | 40.09% | 28.72% |
| Average Basic Shares Outstanding | 338.98% | 339.82% | 324.38% | 94.34% | 68.03% |
| Average Diluted Shares Outstanding | 338.98% | 339.82% | 324.38% | 94.34% | 68.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |